Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee.

JAMA. 2004 Apr 14;291(14):1701-12.

PMID:
15082697
2.

Long term hormone therapy for perimenopausal and postmenopausal women.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004143. doi: 10.1002/14651858.CD004143.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Jan 17;1:CD004143.

PMID:
22786488
3.

Long-term hormone therapy for perimenopausal and postmenopausal women.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J.

Cochrane Database Syst Rev. 2017 Jan 17;1:CD004143. doi: 10.1002/14651858.CD004143.pub5. Review.

PMID:
28093732
4.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
5.

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

Chlebowski RT, Anderson GL, Aragaki AK, Prentice R.

J Natl Cancer Inst. 2015 Nov 5;108(2). pii: djv327. doi: 10.1093/jnci/djv327. Print 2016 Feb. Review.

PMID:
26546117
6.

Postmenopausal hormone replacement therapy: scientific review.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

JAMA. 2002 Aug 21;288(7):872-81. Review.

PMID:
12186605
7.

Recent epidemiological evidence relevant to the clinical management of the menopause.

Shapiro S.

Climacteric. 2007 Oct;10 Suppl 2:2-15. Review.

PMID:
17882666
8.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

9.

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.

Prentice RL.

Semin Reprod Med. 2014 Nov;32(6):419-25. doi: 10.1055/s-0034-1384624. Epub 2014 Oct 16. Review.

10.
11.

Effects of menopausal hormonal therapy on occult breast tumors.

Santen RJ, Song Y, Yue W, Wang JP, Heitjan DF.

J Steroid Biochem Mol Biol. 2013 Sep;137:150-6. doi: 10.1016/j.jsbmb.2013.05.008. Epub 2013 Jun 7. Review.

PMID:
23748149
12.

Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

Chlebowski RT, Anderson GL.

Steroids. 2014 Nov;90:53-9. doi: 10.1016/j.steroids.2014.06.001. Epub 2014 Jun 6. Review.

13.

Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.

Maki PM, Henderson VW.

Climacteric. 2012 Jun;15(3):256-62. doi: 10.3109/13697137.2012.660613. Review.

14.
15.

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.

Harman SM, Vittinghoff E, Brinton EA, Budoff MJ, Cedars MI, Lobo RA, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Taylor HS, Black DM.

Am J Med. 2011 Mar;124(3):199-205. doi: 10.1016/j.amjmed.2010.09.021. Review.

16.

Women's health initiative studies of postmenopausal breast cancer.

Prentice RL.

Adv Exp Med Biol. 2008;617:151-60. doi: 10.1007/978-0-387-69080-3_14. Review.

PMID:
18497039
17.

Menopausal hormone therapy and breast cancer mortality: clinical implications.

Chlebowski RT, Anderson GL.

Ther Adv Drug Saf. 2015 Apr;6(2):45-56. doi: 10.1177/2042098614568300. Review.

18.

The evidence base for HRT: what can we believe?

Langer RD.

Climacteric. 2017 Apr;20(2):91-96. doi: 10.1080/13697137.2017.1280251. Epub 2017 Mar 10. Review.

PMID:
28281363
19.

Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials.

Henderson VW, Lobo RA.

Climacteric. 2012 Jun;15(3):229-34. doi: 10.3109/13697137.2012.656254. Review.

20.

Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene.

Barrett-Connor E, Wenger NK, Grady D, Mosca L, Collins P, Kornitzer M, Cox DA, Moscarelli E, Anderson PW.

J Womens Health. 1998 Sep;7(7):839-47. Review.

PMID:
9785310

Supplemental Content

Support Center